Press Release
Sep 09, 2023
Contact: Chris Martin, IASLC Media Relations, cmartin@davidjamesgroup.com, 630.670.2745
[Singapore September 9, 2023] ⎯ Medical Oncologist Myung-Ju Ahn was awarded the Adi F. Gazdar IASLC Merit Award today at the 2023 IASLC World Conference on Lung Cancer in Singapore.
The Adi F. Gazdar IASLC Merit Award proudly recognizes and honors Dr. Gazdar’s lifelong dedication to lung cancer research through his pioneering work in molecular pathology.
Myung-Ju Ahn is a Professor of Hemato-Oncology at the Department of Medicine, Sungkyunkwan University School of Medicine, Seoul. She is a member of numerous research associations and societies, including the ISLAC, AACR, and ASCO, and is currently Chief of the Executive Committee and Chairperson of the Lung Cancer Disease Committee of the KCSG. She is the current president of the KSMO and was chairperson of the multidisciplinary Immuno-oncology Study Group (2017–2018). She is a board member for the KCA, KSMO, and KALC, and is on the editorial board of the Journal of Thoracic Oncology. Professor Ahn received her medical and doctoral degrees from Hanyang University College of Medicine, Seoul, and completed her residency training at Hanyang University Hospital. She has held numerous research fellowships, including a postdoctoral research fellowship at the Memorial Sloan-Kettering Cancer Center, New York City, and has authored over 250 cancer research publications. Her research interests include the development of predictive and prognostic markers for personalized lung cancer therapy.
She has recently focused on early clinical trials for the development of drug discovery and reposition of targeted drugs and the development of a NSCLC genome atlas. Her accolades for her dedication to cancer research include Best Researcher Award, KMWA (2003); Best Researcher Award, KACO (2015); Boryoung Scientific Award, Korean Cancer Research Foundation (2018), and Highly Cited Researcher, Clavirate Analytics (2019); Daniel C. Ihde Lectureship Award for Medical Oncology (IASLC, 2020).
###
About the IASLC
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 8,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians, and specialists from more than 100 countries. The goal is to increase awareness, collaboration, and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2022.iaslc.org/.